Data Saves Lives: Lessons from the Corona Pandemic and Future Opportunities
summary
The session examines how electronic patient records, health apps and digital doctor–patient communication performed during the COVID-19 crisis and how they can be expanded to fight disease in future. It evaluates the potential of digital health platforms and discusses ensuring data sovereignty and trustworthy data use to improve care, with perspectives from pharma and health-policy leaders (MSD, Pfizer, Johnson & Johnson).
AI-written summary · about
chapters (6)
- 0:00Start
- 13:53Prerequisites
- 19:39Access to Data
- 24:52The Lack of Digital Immunization Registry
- 27:38The Rate of Cancer Screening
- 35:04What Did You Learn as a Pharmaceutical Company from this Collaboration with Science and What Do You Expect from It for the Future
related talks
04mDigital Health and its Emerging Ecosystems
07mOpening Welcome
01h 19mOpportunities and risks of big data in disease surveillance.
11mDismantling Data Tyranny
08mBig Data and the Big Healthcare Impact
02mComplete Video Compilation
30mRocking Innovation
11mConnecting Researchers to Patient and Person Generated Data